Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants (NCT03893032)United States Army Aeromedical Research Laboratory2019-07-17
Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence (NCT03443856)European Organisation for Research and Treatment of Cancer - EORTC2019-07-17
High Dose IL-2 in Combination With Anti-PD-1 (NCT03991130)Gregory Daniels2019-07-17
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT03346135)City of Hope Medical Center2019-07-17
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care (NCT03743649)M.D. Anderson Cancer Center2019-07-17
A Study for PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer (NCT04118933)Xu jianmin2019-07-17
Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive,HR-Positive Metastatic Breast Cancer (NCT04034589)Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2019-07-17
Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN (NCT03726775)Groupe Oncologie Radiotherapie Tete et Cou2019-07-17
Eribulin in Advanced Solitary Fibrous Tumor (NCT03840772)Italian Sarcoma Group2019-07-17
ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer (NCT04028388)Modra Pharmaceuticals2019-07-17
Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy (NCT03889756)Yale University2019-07-17
A Phase 2b Study of Icosabutate in Fatty Liver Disease (NCT04052516)NorthSea Therapeutics B.V.2019-07-17
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer (NCT04253483)Rutgers, The State University of New Jersey2019-07-17
Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006) (NCT03807843)Themis Bioscience GmbH2019-07-16
Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant (NCT04035876)Zhejiang University2019-07-16
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial (NCT03907475)National Cancer Institute (NCI)2019-07-16
AXER-204 in Participants With Chronic Spinal Cord Injury (NCT03989440)ReNetX Bio, Inc.2019-07-16
Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy (NCT04318223)Consorzio Oncotech2019-07-16
Comparison of Topical Silymarin With Hydroquinone in the Treatment of Melasma (NCT03982849)Islamabad Medical and Dental College2019-07-15
A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD (NCT03763318)Biocon Limited2019-07-15
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum (NCT04022213)Memorial Sloan Kettering Cancer Center2019-07-15
Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients (NCT04025450)The First Affiliated Hospital of Soochow University2019-07-15
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma (NCT03915444)HonorHealth Research Institute2019-07-15
The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED) (NCT02393183)Iran University of Medical Sciences2019-07-15
A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy (NCT03941574)Shanghai Henlius Biotech2019-07-15
Microbiota Intervention to Change the Response of Parkinson's Disease (NCT03575195)University of California, San Francisco2019-07-15
Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer (NCT03406468)Maastricht Radiation Oncology2019-07-15
GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL (NCT04021992)Sun Yat-sen University2019-07-15
A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer (NCT04750382)Taizhou Hanzhong biomedical co. LTD2019-07-15
Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma (NCT04267146)Gustave Roussy, Cancer Campus, Grand Paris2019-07-15
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia (NCT03576885)AdventHealth2019-07-15
ENAC Blockade and Arterial Stiffness (NCT03837626)University of Missouri-Columbia2019-07-15
An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis (NCT03943147)Bristol-Myers Squibb2019-07-15
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer (NCT04270591)Haihe Biopharma Co., Ltd.2019-07-15
Impact of Evolocumab in Cardiac Transplant Patients With CAV (NCT03944577)University of Nebraska2019-07-15
Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix (NCT03644342)Michelle S Ludwig2019-07-15
Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention (NCT03686813)Duke University2019-07-15
Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids (NCT03861455)University Hospital, Toulouse2019-07-15
Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced Cholangiocarcinoma (NCT03982680)Jiangmen Central Hospital2019-07-13
A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty (NCT03981419)Alkahest, Inc.2019-07-12
The Effect of Donepezil on Glycemic Control in Type II Diabetics (NCT04507438)University of Maryland, Baltimore2019-07-12
Improving SCI Rehabilitation Interventions by Retraining the Brain (NCT03892746)The Cleveland Clinic2019-07-12
PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr) (NCT03658447)Peter MacCallum Cancer Centre, Australia2019-07-12
A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome (NCT04035668)Novartis Pharmaceuticals2019-07-12
Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm (NCT03995680)Swiss Tropical & Public Health Institute2019-07-12
Improving Tissue Oxygenation in Breast Reconstruction Surgery (NCT04020172)Dr. Glenio Mizubuti (MD, PhD)2019-07-12
Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT (NCT03861091)Wake Forest University Health Sciences2019-07-12
A Personalized Behavioral Intervention to Improve Physical Activity, Sleep and Cognition in Sedentary Older Adults (NCT03959202)Johns Hopkins University2019-07-11
A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan (NCT04070313)TTY Biopharm2019-07-11
Addressing Heavy Alcohol Use Consumption With Kudzu (NCT03709043)Glenn-Milo Santos2019-07-11
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer (NCT03777124)Jiangsu HengRui Medicine Co., Ltd.2019-07-11
68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging (NCT03606837)University Hospital, Bordeaux2019-07-11
A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris (NCT04018885)Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.2019-07-11
Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial (NCT03855332)University of Oxford2019-07-11
Chemotherapy w/wo WeiLeShu in Metastatic Colorectal Cancer (NCT04021589)Zhejiang University2019-07-11
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor (NCT04008797)Eisai Inc.2019-07-11
Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma (NCT03974243)Chipscreen Biosciences, Ltd.2019-07-11
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer (NCT04019327)Memorial Sloan Kettering Cancer Center2019-07-11
Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular Lymphoma (NCT03828448)TG Therapeutics, Inc.2019-07-10
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03670966)Fred Hutchinson Cancer Center2019-07-10
Dual Vaccine Trial in Myeloproliferative Neoplasms (NCT04051307)Inge Marie Svane2019-07-10
Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow (NCT02757885)Emory University2019-07-10
Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus (NCT04014023)Daewoong Pharmaceutical Co. LTD.2019-07-10
High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS) (NCT04126460)Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University2019-07-10
A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough (NCT03979638)Bellus Health Inc. - a GSK company2019-07-10
Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer (NCT03985670)Henan Cancer Hospital2019-07-10
Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. (NCT03958955)LEO Pharma2019-07-09
A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam (NCT03978091)National Institute of Allergy and Infectious Diseases (NIAID)2019-07-09
Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (NCT04094142)Seoul National University Hospital2019-07-09
Optimizing PTCy Dose and Timing (NCT03983850)National Cancer Institute (NCI)2019-07-09
Food Allergen OIT for Shrimp and Cashew (NCT03504774)Sayantani B. Sindher2019-07-09
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma (NCT03840967)Shadia Jalal, MD2019-07-09
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC (NCT04015661)Fuzhou General Hospital2019-07-09
A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment (NCT04059081)Deok-Hwan Yang2019-07-09
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) (NCT03974022)Dizal Pharmaceuticals2019-07-09
Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC (NCT03952325)Odonate Therapeutics, Inc.2019-07-09
Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus (NCT05056935)Newsoara Biopharma Co., Ltd.2019-07-09
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer (NCT03951415)Leiden University Medical Center2019-07-08
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer (NCT03971409)Laura Huppert, MD, BA2019-07-08
Evaluation of Polychemotherapy With XELOXIRI-3 in Elderly or Frail Patients With Advanced Pancreatic Adenocarcinoma (NCT03974854)Centre Hospitalier Universitaire de Besancon2019-07-08
Dental Plaque Removal Ability of Prototype Power Toothbrush Versus a Manual Toothbrush in Healthy Participants (NCT03809910)GlaxoSmithKline2019-07-08
Neurosteroids in PTSD - Biomarkers to Therapeutics (NCT03491007)VA Office of Research and Development2019-07-08
Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease (NCT03980938)EIP Pharma Inc2019-07-08
A Fabry Disease Gene Therapy Study (NCT04040049)Spur Therapeutics2019-07-08
ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC (NCT04032847)Achilles Therapeutics UK Limited2019-07-08
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma (NCT03794349)Children's Oncology Group2019-07-08
Stem Cell Gene Therapy for Cystinosis (NCT03897361)University of California, San Diego2019-07-08
Norursodeoxycholic Acid vs. Placebo in NASH (NCT05083390)Dr. Falk Pharma GmbH2019-07-08
Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult (NCT03830177)Ann & Robert H Lurie Children's Hospital of Chicago2019-07-08
A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC (NCT04023617)Peking University Cancer Hospital & Institute2019-07-08
Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN (NCT03878979)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2019-07-08
Maternal Depression Treatment in HIV (NCT03892915)RAND2019-07-08
Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes (NCT03746769)City of Hope Medical Center2019-07-07
Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma (NCT04162119)Chinese PLA General Hospital2019-07-07
A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients (NCT04056442)Stero Biotechs Ltd.2019-07-07
Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma (NCT04163302)Chinese PLA General Hospital2019-07-07
Very Small Embryonic-like Stem Cells for Facial Skin Antiaging (NCT03976206)Fuda Cancer Hospital, Guangzhou2019-07-06
Very Small Embryonic-like Stem Cells for Knee Osteoarthritis (NCT03975101)Fuda Cancer Hospital, Guangzhou2019-07-05
The University of Michigan PCOS Intervention Using Nutritional Ketosis (NCT03987854)University of Michigan2019-07-05
Regional Anticoagulation of Dialysis Circuits With a Calcium-free Citrate-containing Dialysate (NCT03842657)University Hospital, Toulouse2019-07-05
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.